Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 35553t | IM / RA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | HM9N5 and 3334Y | IM / LA |
Patient came back to report adverse event at the site of Shingrix vaccine. Patient reported that a small bubble developed at the site of the injection, the bubble later pupped and patient had an open soar. Patient reported not scratching the area. Patient applied bacitracin and covered the area with bandage. When patient came to pharmacy on 5/24, the area did not feel warm to touch. After visiting the pharmacy patient went to see his doctor. No other medications were prescribed, the doctor told him to keep an eye on it and report any changes, especially if area started to redden
blood pressure, high cholesterol
atorvastatin, lisinopril, omeprazole